Oh, the drama! Misconceptions about nurses on TV
To: Ethics inbox From: BSN, RN from Rochester, New York Subject: Portrayal of nurses on television I am writing as a concerned RN. I…
Women’s Health
ANA on the Frontline: Sparks fly at ANA-ANCC conferences
Nurses come together to improve practice, work environments, and healthcare. While one speaker encouraged nurses to find their “inner spark,” the energy among nurses…
Evidence-based epilepsy care
EPILEPSY is one of the most common disorders of the central nervous system, affecting 65 million people worldwide—3.4 million in the United States. It…
Atypical presentation of myocardial infarction
Cardiovascular disease remains the leading cause of death in women, but it’s often under-recognized because of atypical symptoms. Women may experience vague symptoms that…
Looking back: Nurses who stepped up to care for patients with AIDS when others wouldn’t
By Julie Cullen, Managing Editor, American Nurse Today The 1980s AIDS crisis brought out the best and worst in some people. The worst, in…
The launch of Nursing Now
Raising the profile of nursing to improve health and healthcare here and globally (more…)
Centralized vs decentralized staffing: Two case studies
Centralized staffing manages staffing through a central office. Decentralized staffing occurs at a hospital or unit level. A hybrid model combines centralized and decentralized…
Oral anticoagulants: Pharmacologic management update
Stay-up-to-date to avoid complications and achieve the best treatment for patients. Takeaways: This article discusses the use of oral anticoagulants. Indications, side effects and…
FDA approves first PI3K inhibitor for breast cancer
On May 24, the FDA approved Piqray (alpelisib) tablets, to be used in combination with fulvestrant, to treat postmenopausal women, and men, with hormone…
Prescription drugs in pregnant and nursing women
On May 8, the FDA released two draft guidance documents designed to improve understanding of effects of prescription drugs in pregnant and nursing women.…
Nursing considerations for procedural sedation and analgesia: Part 1
This first in a two-part series reviews patient assessment, red flags, and pharmacologic agents. Takeaways: Registered nurses providing moderate procedural sedation and analgesia must…
FDA approves new osteoporosis treatment
On April 9, the FDA approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of fracture. (more…)
Oh, the drama! Misconceptions about nurses on TV
To: Ethics inbox From: BSN, RN from Rochester, New York Subject: Portrayal of nurses on television I am writing as a concerned…
ANA on the Frontline: Sparks fly at ANA-ANCC conferences
Nurses come together to improve practice, work environments, and healthcare. While one speaker encouraged nurses to find their “inner spark,” the energy…
Evidence-based epilepsy care
EPILEPSY is one of the most common disorders of the central nervous system, affecting 65 million people worldwide—3.4 million in the United…
Atypical presentation of myocardial infarction
Cardiovascular disease remains the leading cause of death in women, but it’s often under-recognized because of atypical symptoms. Women may experience vague…
Looking back: Nurses who stepped up to care for patients with AIDS when others wouldn’t
By Julie Cullen, Managing Editor, American Nurse Today The 1980s AIDS crisis brought out the best and worst in some people. The…
The launch of Nursing Now
Raising the profile of nursing to improve health and healthcare here and globally (more…)
Centralized vs decentralized staffing: Two case studies
Centralized staffing manages staffing through a central office. Decentralized staffing occurs at a hospital or unit level. A hybrid model combines centralized…
Oral anticoagulants: Pharmacologic management update
Stay-up-to-date to avoid complications and achieve the best treatment for patients. Takeaways: This article discusses the use of oral anticoagulants. Indications, side…
FDA approves first PI3K inhibitor for breast cancer
On May 24, the FDA approved Piqray (alpelisib) tablets, to be used in combination with fulvestrant, to treat postmenopausal women, and men,…
Prescription drugs in pregnant and nursing women
On May 8, the FDA released two draft guidance documents designed to improve understanding of effects of prescription drugs in pregnant and…
Nursing considerations for procedural sedation and analgesia: Part 1
This first in a two-part series reviews patient assessment, red flags, and pharmacologic agents. Takeaways: Registered nurses providing moderate procedural sedation and…
FDA approves new osteoporosis treatment
On April 9, the FDA approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of fracture. (more…)